Project Grant R56DK135699
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$235K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $284,517 Project Grant (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) to Electronic Biosciences, Inc. to develop a point-of-care diagnostic assay for detecting autoantibodies associated with type 1 diabetes (T1D). This project aims to leverage nanopore technology to create a rapid, cost-effective test for screening populations, especially children, for T1D biomarkers that appear...
This federal Project Grant award, R01DK140781, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $1,449,016 award aims to use advanced immunoproteomics technologies to comprehensively screen for microbial infections associated with increased or decreased risk of islet autoimmunity and type 1 diabetes in children participating in the TEDDY study. The project...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $215,128 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Colorado-Denver. The funding supports a 3-year research study to investigate the role and origin of hybrid insulin peptides (HIPs) in the pathogenesis of type 1 diabetes. The key objectives are to: Study the role of disease-relevant HIPs formed by the enzyme cathepsin D in...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $823,473 Cooperative Agreement under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to The General Hospital Corporation (Massachusetts General Hospital) to study longitudinal omics-based trajectories of type 2 diabetes subtypes. The five-year project aims to use multi-omic data to refine definitions of prediabetes and type 2 diabetes, describe associations between...
This Cooperative Agreement award of $1,232,846 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to study the mechanisms of beta cell death in type 1 diabetes. The primary goals are to develop a microfluidic platform with syngeneic human cell types, including induced pluripotent stem cell-derived pancreatic endocrine cells, blood vessels, macrophages,...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $324,998 to support the development of advanced stem cell-derived pancreatic islet cell technologies for type 1 diabetes treatment. The key products and services to be delivered include: Assessing the impact of genetically modifying stem cell-derived islet cells to be more resilient to...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a 5-year, $271,385 Cooperative Agreement (Award ID: U01DK140735) to the University of Colorado Denver under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The purpose of this award is to investigate the impact of type 1 diabetes (T1D) on neurocognitive and psychosocial functioning in pre-pubertal children. The research will examine the long-term effects of diabetic...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $500,928 to Pupil Bio, Inc. to develop an early detection test for Type 1 Diabetes (T1D) using next-generation sequencing (NGS) analysis of cell-free DNA (cfDNA) methylation patterns specific to pancreatic beta cells. The goal is to create a non-invasive diagnostic tool that can identify the early stages of T1D...
This federal Project Grant award of $444,867.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to investigate the role of the UPR transducer XBP1 in pancreatic beta cell survival and function under metabolic stress. The research will use a novel mouse model to elucidate the pathological role of XBP1s in beta cell integrity under metabolic stress, in order to...
This $698,646 federal Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to study the functional and disease relevance of distinct pancreatic beta-cell subtypes, with a focus on understanding their epigenetic regulation and relationship to type 2 diabetes (T2D). The research will use novel single-cell epigenomic tools, conditional...